J3M-MC-JZQB app for iPhone and iPad

4.6 ( 5696 ratings )

Health & Fitness
Developer: Medable, Inc.

Free

Current version: 1.1, last update: 2 days ago
First release : 03 Jul 2024
App size: 100.37 Mb

A Multicenter, Randomized, Phase 3 Study Comparing LY3537982 and Pembrolizumab to Placebo and Pembrolizumab as First-Line Treatment in Patients with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression (TPS ≥ 50%). This app is specifically intended for participants in the J3M-MC-JZQB study only.